A Novel Hexokinases Inhibitor Based on Molecularly Imprinted Polymer for Combined Starvation and Enhanced Photothermal Therapy of Malignant Tumors

ACS Appl Mater Interfaces. 2023 May 31;15(21):25898-25908. doi: 10.1021/acsami.3c00079. Epub 2023 May 16.

Abstract

The heat tolerance of tumor cells induced by heat shock proteins (HSPs) is the major factor that seriously hinders further application of PTT, as it can lead to tumor inflammation, invasion, and even recurrence. Therefore, new strategies to inhibit HSPs expression are essential to improve the antitumor efficacy of PTT. Here, we prepared a novel nanoparticle inhibitor by synthesizing molecularly imprinted polymers with a high imprinting factor (3.1) on the Prussian Blue surface (PB@MIP) for combined tumor starvation and photothermal therapy. Owing to using hexokinase (HK) epitopes as the template, the imprinted polymers could inhibit the catalytic activity of HK to interfere with glucose metabolism by specifically recognizing its active sites and then achieve starvation therapy by restricting ATP supply. Meanwhile, MIP-mediated starvation downregulated the ATP-dependent expression of HSPs and then sensitized tumors to hyperthermia, ultimately improving the therapeutic effect of PTT. As the inhibitory effect of PB@MIP on HK activity, more than 99% of the mice tumors were eliminated by starvation therapy and enhanced PTT.

Keywords: Prussian Blue; enzyme inhibitor; molecular imprinted polymer; photothermal therapy; tumor starvation.

MeSH terms

  • Adenosine Triphosphate
  • Animals
  • Hexokinase
  • Hyperthermia, Induced*
  • Mice
  • Molecular Imprinting*
  • Molecularly Imprinted Polymers
  • Nanoparticles* / chemistry
  • Neoplasms* / drug therapy
  • Photothermal Therapy

Substances

  • Molecularly Imprinted Polymers
  • Hexokinase
  • Adenosine Triphosphate